Cutler Group LP Revolution Medicines, Inc. Transaction History
Cutler Group LP
- $307 Million
- Q1 2024
A detailed history of Cutler Group LP transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Cutler Group LP holds 4,200 shares of RVMD stock, worth $159,054. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,200Holding current value
$159,054% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding RVMD
# of Institutions
303Shares Held
189MCall Options Held
186KPut Options Held
672K-
Vanguard Group Inc Valley Forge, PA16.6MShares$629 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA13.5MShares$513 Million2.75% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$508 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$446 Million0.08% of portfolio
-
Janus Henderson Group PLC London, X010.2MShares$386 Million0.21% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.32B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...